Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
56.25
+2.51 (4.67%)
At close: Sep 26, 2025, 4:00 PM EDT
57.00
+0.75 (1.33%)
After-hours: Sep 26, 2025, 6:22 PM EDT
Kymera Therapeutics Employees
Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.
Employees
188
Change (1Y)
1
Growth (1Y)
0.53%
Revenue / Employee
$237,824
Profits / Employee
-$1,465,074
Market Cap
4.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 188 | 1 | 0.53% |
| Dec 31, 2023 | 187 | 20 | 11.98% |
| Dec 31, 2022 | 167 | 26 | 18.44% |
| Dec 31, 2021 | 141 | 66 | 88.00% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KYMR News
- 18 days ago - Kymera Therapeutics, Inc. (KYMR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - Kymera Therapeutics, Inc. (KYMR) Presents At Citi's 2025 Biopharma Back To School Conference Transcript - Seeking Alpha
- 24 days ago - Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 4 weeks ago - Kymera Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 6 weeks ago - The Best Small-Cap Stocks to Buy Now - Kiplinger
- 6 weeks ago - Kymera Therapeutics, Inc. (KYMR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Kymera Therapeutics Announces Pricing of $250 Million Public Offering - GlobeNewsWire